CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
Cited by 66
Related Papers
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study
|American Journal of Epidemiology|2018|73
Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
|Frontiers in Neurology|2019|32
Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review
|Frontiers in Aging Neuroscience|2017|12
Clinical assessment and genomic landscape of a consanguineous family with three Kallmann syndrome descendants
|Asian Journal of Andrology|2010|8